COVAX, the global vaccine distribution initiative, is well behind its goal of delivering 2 billion doses this year due to under-investment, vaccine nationalism and export restrictions.
L’expertise universitaire, l’exigence journalistique
Articles sur COVID-19
Affichage de 2941 à 2960 de 7971 articles
A hike in the minimum wage could jeopardise Australia’s post-COVID recovery, says the Morrison government. That’s an outdated economic idea.
Canadians who had poor finances and health were more likely to report financial stress across the first several months of the pandemic.
The pandemic has led some people on working holiday visas to apply for permanent residency, while others are going to stick out their two years and head home.
The seasons can affect transmission of the virus – but this will likely be dwarfed by the impact of public health measures.
The easing of lockdown restrictions is good news for struggling high streets, but consumers are still wary.
Despite indications the Samoan government was out of favour, few predicted it could lose power.
The challenge now is to address the understandable concerns and prevent them from contaminating the broader public dialogue on COVID-19 vaccination.
Analysis of almost 100,000 tweets reveals how news reports can change the way people feel about vaccination.
This year is a whole new ball game for pandemic politics. For a prime minister not accustomed to pressure, Scott Morrison is proving far less equipped.
With changing recommendations about AstraZeneca’s COVID-19 vaccine making headlines, many people have questions about its use.
African governments, firms and donor agencies should align their efforts to support the local manufacture of vaccines and other health equipment in African countries.
The mechanisms behind vaccine-related and pill-related clots are quite different.
After lockdowns and bans on flying, tourists will have high expectations and demands.
What restaurants, bars and pubs can do to help people happily hand over their data.
This week’s unwelcome medical advice about the AstraZeneca vaccine is the latest setback to the rollout and the Morrison government.
Beyond the immediate questions of NHS funding and the timing of decisions, some controversial governance choices need to be urgently addressed.
We’ll need mass vaccination hubs and expanded GP vaccination clinics to deliver jabs to millions of Australians.
This shift in focus away from AstraZeneca to the Pfizer vaccine has serious impacts on the timing of the rollout and public confidence in the AstraZeneca vaccine.
The coronavirus pandemic has entrenched educational technologies in schools. Parents and guardians have been forced to relinquish their children’s privacy, without assurance of protection.
Les contributeurs les plus fréquents
-
Professorial Fellow, University of Canberra
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Economics, UNSW Sydney
-
Chair in Epidemiology, Deakin University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Professor of Biostatistics and Epidemiology, University of South Australia
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Senior Research Fellow in Global Health, University of Southampton
-
Visiting Fellow, Crawford School of Public Policy, Australian National University
-
Professor of Medicine, University of East Anglia
-
Associate Professor, School of Population Health, UNSW Sydney
-
Professor of Public Health, University of Sheffield
-
Professor of Medicine, University of Virginia
-
Associate Professor of Bioethics, University of Portsmouth
